| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1006541241 |
| P356 | DOI | 10.1007/S00432-003-0524-9 |
| P698 | PubMed publication ID | 14727106 |
| P2093 | author name string | H C Diener | |
| S Koeppen | |||
| D Strumberg | |||
| M E Scheulen | |||
| T J Postma | |||
| P C Huijgens | |||
| J J Heimans | |||
| B Kiburg | |||
| C C P Verstappen | |||
| K Renzing-Köhler | |||
| R Körte | |||
| P2860 | cites work | The effect of nerve growth factor, ciliary neurotrophic factor, and ACTH analogs on cisplatin neurotoxicity in vitro | Q72335055 |
| Protection against cisplatin induced neurotoxicity by ORG 2766: histological and electrophysiological evidence | Q72537869 | ||
| The neurotrophic analogue of ACTH(4-9), Org 2766, protects against experimental allergic neuritis | Q72557994 | ||
| ACTH accelerates recovery of neuromuscular function following crushing of peripheral nerve | Q72896284 | ||
| Chemotherapy-induced peripheral neuropathy | Q77944571 | ||
| A pilot study on the influence of a corticotropin (4-9) analogue on Vinca alkaloid-induced neuropathy | Q28326902 | ||
| Clinical and electrophysiological studies in vincristine induced neuropathy | Q28373272 | ||
| The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo | Q33188860 | ||
| Vincristine treatment of advanced cancer: a cooperative study of 392 cases. | Q33463170 | ||
| Chemoprotectants: a review of their clinical pharmacology and therapeutic efficacy. | Q33588520 | ||
| Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation | Q33755596 | ||
| Melanocortins and the treatment of nervous system disease. Potential relevance to the skin? | Q33921707 | ||
| Grading of chemotherapy-induced peripheral neuropathy | Q33977591 | ||
| David and Goliath - the slingshot that started the neuropeptide revolution | Q34060953 | ||
| The effects of an ACTH (4-9) analogue on development of cisplatin neuropathy in testicular cancer: a randomized trial | Q36724012 | ||
| Vincristine neurotoxicity. Pathophysiology and management. | Q39752416 | ||
| Vincristine neurotoxicity | Q39901026 | ||
| Neurotoxicity secondary to antineoplastic drugs | Q40739607 | ||
| The potential of melanotropins in the treatment of nervous system diseases | Q40855163 | ||
| The ACTH(4-9) analog ORG 2766 and recovery after brain damage in animal models--a review | Q41147510 | ||
| Pharmacological aspects of the influence of melanocortins on the formation of regenerative peripheral nerve sprouts | Q41322045 | ||
| Effects of the ACTH(4-9) analogue, ORG 2766, on vincristine cytotoxicity in two human lymphoma cell lines, U937 and U715. | Q41483240 | ||
| Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat. | Q41753082 | ||
| Vinca alkaloid neuropathy: nerve biopsy studies in rats and in man. | Q42231713 | ||
| Vincristine neuropathy. Clinical and electrophysiological observations | Q42232020 | ||
| Vincristine-induced neuropathy: A clinical study of fifty leukemic patients | Q42239801 | ||
| Long-term effects of vincristine on the peripheral nervous system | Q42288782 | ||
| NGF prevention of neurotoxicity induced by cisplatin, vincristine and taxol depends on toxicity of each drug and NGF treatment schedule: in vitro study of adult rat sympathetic ganglion explants | Q42541747 | ||
| Insulin-like growth factor-I prevents development of a vincristine neuropathy in mice | Q42545287 | ||
| Glutamate ameliorates experimental vincristine neuropathy | Q42553227 | ||
| Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer | Q43929645 | ||
| A randomized, multicenter, double-blind, placebo-controlled, dose-finding study of ORG 2766 in the prevention or delay of cisplatin-induced neuropathies in women with ovarian cancer | Q46452153 | ||
| Cisplatin-induced neuropathy in mature rats: effects of the melanocortin-derived peptide ORG 2766. | Q48822332 | ||
| Protective effects of a neurotrophic ACTH(4-9) analog on cisplatin ototoxicity in relation to the cisplatin dose: an electrocochleographic study in albino guinea pigs. | Q50503348 | ||
| Org.2766 improves functional and electrophysiological aspects of regenerating sciatic nerve in the rat. | Q51791790 | ||
| The features of peripheral nerve lesions in young and adult rabbits after vincristine administration. | Q52210956 | ||
| Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in rats. | Q54386732 | ||
| The ACTH/MSH(4-9) analogue ORG 2766 stimulates microtubule formation in axons of central neurons of the snail Lymnaea stagnalis | Q67506640 | ||
| Ganglioside treatment of vincristine-induced neuropathy. An electrophysiologic study | Q68382791 | ||
| Beneficial effect of Org 2766 in treatment of peripheral neuropathy in streptozocin-induced diabetic rats | Q69327325 | ||
| Org.2766 stimulates collateral sprouting in the soleus muscle of the rat following partial denervation | Q69349787 | ||
| Studies on the pathogenesis of vincristine-induced neuropathy | Q70171867 | ||
| Org.2766 protects from cisplatin-induced neurotoxicity in rats | Q70191617 | ||
| In vivo modulation of vincristine-induced neurotoxicity in Lymnaea stagnalis, by the ACTH(4-9) analogue Org 2766 | Q71833370 | ||
| Effect of cisplatin and ACTH4-9 on neural transport in cisplatin induced neurotoxicity | Q71885107 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 153-160 | |
| P577 | publication date | 2004-01-16 | |
| P1433 | published in | Journal of Cancer Research and Clinical Oncology | Q2081599 |
| P1476 | title | Lack of neuroprotection by an ACTH (4-9) analogue. A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphoma | |
| P478 | volume | 130 |
| Q34717624 | Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75 NTR |
| Q92865754 | Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review |
| Q43058277 | Chemotherapy-induced peripheral neuropathy: an unresolved issue |
| Q33717608 | North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled study |
| Q35345734 | Platinum-induced neurotoxicity and preventive strategies: past, present, and future |
| Q80932791 | Recent publications in hematological oncology |
| Q37410650 | The search for treatments to reduce chemotherapy-induced peripheral neuropathy |
| Q28078232 | Vincristine-induced peripheral neuropathy in pediatric cancer patients |
Search more.